The cytosolic sialidase Neu2 is degraded by autophagy during myoblast atrophy.

[1]  M. A. Chambers,et al.  TNF induction of atrogin-1/MAFbx mRNA depends on Foxo4 expression but not AKT-Foxo1/3 signaling. , 2008, American journal of physiology. Cell physiology.

[2]  F. Colombo,et al.  The enzymatic activity of sialidase Neu2 is inversely regulated during in vitro myoblast hypertrophy and atrophy. , 2008, Biochemical and biophysical research communications.

[3]  A. Goldberg,et al.  FoxO3 coordinately activates protein degradation by the autophagic/lysosomal and proteasomal pathways in atrophying muscle cells. , 2007, Cell metabolism.

[4]  A. Goldberg,et al.  FoxO3 controls autophagy in skeletal muscle in vivo. , 2007, Cell metabolism.

[5]  C. Scuoppo,et al.  Conditional Activation of MET in Differentiated Skeletal Muscle Induces Atrophy* , 2007, Journal of Biological Chemistry.

[6]  C. Stewart,et al.  Waste management - cytokines, growth factors and cachexia. , 2006, Cytokine & growth factor reviews.

[7]  F. Colombo,et al.  Insulin‐like growth factor 1 signaling regulates cytosolic sialidase Neu2 expression during myoblast differentiation and hypertrophy , 2006, The FEBS journal.

[8]  M. Tisdale,et al.  Mechanism of induction of muscle protein degradation by angiotensin II. , 2006, Cellular signalling.

[9]  E. Clementi,et al.  Follistatin induction by nitric oxide through cyclic GMP: a tightly regulated signaling pathway that controls myoblast fusion , 2006, The Journal of cell biology.

[10]  D. Taillandier,et al.  Lysosomal proteolysis in skeletal muscle. , 2005, The international journal of biochemistry & cell biology.

[11]  S. Lecker,et al.  Ubiquitin-protein ligases in muscle wasting. , 2005, The international journal of biochemistry & cell biology.

[12]  P. Costelli,et al.  Ca(2+)-dependent proteolysis in muscle wasting. , 2005, The international journal of biochemistry & cell biology.

[13]  Mark M. Kockx,et al.  Amino Acid Deprivation Induces Both Apoptosis and Autophagy in Murine C2C12 Muscle Cells , 2005, Biotechnology Letters.

[14]  M. Tisdale,et al.  Angiotensin II directly induces muscle protein catabolism through the ubiquitin–proteasome proteolytic pathway and may play a role in cancer cachexia , 2005, British Journal of Cancer.

[15]  D. Mann,et al.  TNF-acts via p 38 MAPK to stimulate expression of the ubiquitin ligase atrogin 1 / MAFbx in skeletal muscle , 2005 .

[16]  N. Mizushima.  Methods for monitoring autophagy. , 2004, The international journal of biochemistry & cell biology.

[17]  A. Goldberg,et al.  IGF-I stimulates muscle growth by suppressing protein breakdown and expression of atrophy-related ubiquitin ligases, atrogin-1 and MuRF1. , 2004, American journal of physiology. Endocrinology and metabolism.

[18]  V. Sartorelli,et al.  Molecular and Cellular Determinants of Skeletal Muscle Atrophy and Hypertrophy , 2004, Science's STKE.

[19]  S. Furuta,et al.  Ras is involved in the negative control of autophagy through the class I PI3-kinase , 2004, Oncogene.

[20]  Eric P Hoffman,et al.  Deacetylase inhibitors increase muscle cell size by promoting myoblast recruitment and fusion through induction of follistatin. , 2004, Developmental cell.

[21]  Marco Sandri,et al.  Foxo Transcription Factors Induce the Atrophy-Related Ubiquitin Ligase Atrogin-1 and Cause Skeletal Muscle Atrophy , 2004, Cell.

[22]  G. Borsani,et al.  Properties of Recombinant Human Cytosolic Sialidase HsNEU2 , 2004, Journal of Biological Chemistry.

[23]  W. Mitch,et al.  Activation of caspase-3 is an initial step triggering accelerated muscle proteolysis in catabolic conditions. , 2004, The Journal of clinical investigation.

[24]  D. Glass,et al.  Molecular mechanisms modulating muscle mass. , 2003, Trends in molecular medicine.

[25]  F. Colombo,et al.  Overexpression of cytosolic sialidase Neu2 induces myoblast differentiation in C2C12 cells , 2003, FEBS letters.

[26]  D. E. Goll,et al.  The calpain system. , 2003, Physiological reviews.

[27]  G. Pavlath,et al.  IL-4 Acts as a Myoblast Recruitment Factor during Mammalian Muscle Growth , 2003, Cell.

[28]  M. Drost,et al.  Lysosomal dysfunction in muscle with special reference to glycogen storage disease type II. , 2003, Biochimica et biophysica acta.

[29]  D. Glass.  Signalling pathways that mediate skeletal muscle hypertrophy and atrophy , 2003, Nature Cell Biology.

[30]  M. Nakagawa,et al.  The first molecular evidence that autophagy relates rimmed vacuole formation in chloroquine myopathy. , 2002, Journal of biochemistry.

[31]  M. Sandri.  Apoptotic signaling in skeletal muscle fibers during atrophy , 2002, Current opinion in clinical nutrition and metabolic care.

[32]  A. Goldberg,et al.  Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[33]  D. Attaix,et al.  Identification of cathepsin L as a differentially expressed message associated with skeletal muscle wasting. , 2001, The Biochemical journal.

[34]  G. Yancopoulos,et al.  Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo , 2001, Nature Cell Biology.

[35]  D J Glass,et al.  Identification of Ubiquitin Ligases Required for Skeletal Muscle Atrophy , 2001, Science.

[36]  M. Colombo,et al.  A novel assay to study autophagy: regulation of autophagosome vacuole size by amino acid deprivation. , 2001, Journal of cell science.

[37]  D. Turk,et al.  Lysosomal cysteine proteases: facts and opportunities , 2001, The EMBO journal.

[38]  J. Müthing,et al.  Characterization of cytosolic sialidase from Chinese hamster ovary cells: part II. Substrate specificity for gangliosides. , 2001, Carbohydrate research.

[39]  J. Müthing,et al.  Characterization of cytosolic sialidase from Chinese hamster ovary cells: part I: cloning and expression of soluble sialidase in Escherichia coli. , 2001, Carbohydrate research.

[40]  Antonio Musarò,et al.  Localized Igf-1 transgene expression sustains hypertrophy and regeneration in senescent skeletal muscle , 2001, Nature Genetics.

[41]  Yi-Ping Li,et al.  NF-κB mediates the protein loss induced by TNF-α in differentiated skeletal muscle myotubes , 2000 .

[42]  D. Figarella-Branger,et al.  Linkage of X-linked myopathy with excessive autophagy (XMEA) to Xq28 , 2000, European Journal of Human Genetics.

[43]  A. Musarò,et al.  Maturation of the Myogenic Program Is Induced by Postmitotic Expression of Insulin-Like Growth Factor I , 1999, Molecular and Cellular Biology.

[44]  A. Goldberg,et al.  Muscle protein breakdown and the critical role of the ubiquitin-proteasome pathway in normal and disease states. , 1999, The Journal of nutrition.

[45]  C. Guézennec,et al.  Coordinate activation of lysosomal, Ca 2+-activated and ATP-ubiquitin-dependent proteinases in the unweighted rat soleus muscle. , 1996, The Biochemical journal.

[46]  K. Sato,et al.  Involvement of an endogenous sialidase in skeletal muscle cell differentiation. , 1996, Biochemical and biophysical research communications.

[47]  D. Taillandier,et al.  Sensitivity and protein turnover response to glucocorticoids are different in skeletal muscle from adult and old rats. Lack of regulation of the ubiquitin-proteasome proteolytic pathway in aging. , 1995, The Journal of clinical investigation.

[48]  Robert J. Schwartz,et al.  Myogenic Vector Expression of Insulin-like Growth Factor I Stimulates Muscle Cell Differentiation and Myofiber Hypertrophy in Transgenic Mice (*) , 1995, The Journal of Biological Chemistry.

[49]  A. Goldberg,et al.  Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules , 1994, Cell.

[50]  H. Kawasaki,et al.  Molecular cloning and expression of cDNA encoding rat skeletal muscle cytosolic sialidase. , 1993, The Journal of biological chemistry.

[51]  M. Rechsteiner,et al.  Degradation of microinjected proteins: Effects of lysosomotropic agents and inhibitors of autophagy , 1983, Journal of cellular physiology.

[52]  P. Seglen,et al.  3-Methyladenine: specific inhibitor of autophagic/lysosomal protein degradation in isolated rat hepatocytes. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[53]  S. Dimauro,et al.  Lysosomal glycogen storage disease with normal acid maltase , 1981, Neurology.